AMBRISENTAN OrPha cpr pell 5 mg 30 cpr pell
7680675000012
CH-67500
C02KX02
02.07.1.
Active substances:
Reimbursement limitations:
FLUDARA
Traitement de la leucémie lymphoïde chronique (LLC) à cellules B. Le traitement de première intention …
1 / 3
google
Details
- Product number
- 6750001
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- ambrisentanum 5 mg, cellulosum microcristallinum, lactosum monohydricum 47.5 mg, carmellosum natricum conexum corresp. natrium 0.16 mg, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, E 129 0.022 mg, lecithinum ex soja, E 171, pro compresso obducto.
Articles (1)
Ambrisentan OrPha 5 mg, Filmtabletten
Filmtabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
ambrisentanum
|
5.0 MG | Substance | Wirkstoff (Principe actif) |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
lactosum monohydricum
|
47.5 MG | Substance | HBESI |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
natrium
|
0.16 MG | Substance | HBESI |
|
magnesii stearas
|
- | Substance | HNIDK |
|
poly(alcohol vinylicus)
|
- | Substance | HNIDK |
|
macrogolum 3350
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
E 129
|
0.022 MG | Substance | HBESI |
|
lecithinum ex soja
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
Reimbursement information
Public price
CHF 898.75
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/10/2023
Authorization holder
OrPha Swiss GmbH
8700 Küsnacht ZH
Authorization information
- Swissmedic authorization number
- 67500
- Drug name
- Ambrisentan OrPha, Filmtabletten
- Galenic form
- FILM
- ATC Code
- C02KX02
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 16/12/2022
- Authorization expiration date
- 15/12/2027
- IT number
- 02.07.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- AMBRISENTAN OrPha cpr pell 5 mg 30 cpr pell
- Description (DE)
- AMBRISENTAN OrPha Filmtabl 5 mg 30 Filmtabl
- Market launch
- 16/12/2022
- Narcotic (BTM)
- No